Dementia with Lewy bodies;Demencia con cuerpos de Lewy

Neurologia

Volumn 15, Issue 1, 2000, Pages 15-21

  Marti Masso J F ^a,b   Ruiz Martinez J ^a  

^a Hospital Nuestra Senora de Aranzazu   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Dementia; Dementia with Lewy bodies; Parkinsonism

Indexed keywords

ALZHEIMER DISEASE; AMNESIA; BRAIN CORTEX; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; HALLUCINATION; LEWY BODY; PARKINSON DISEASE; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SYNCOPE;

AGED; BRAIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEWY BODIES; PARKINSON DISEASE;

EID: 0034008516     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990; 95: 119-139.
2. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, De Teresa R et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990; 40: 1-8.
3. Del Ser T. Enfermedad por cuerpos de Lewy difusos. En: López-Pousa S, Vilalta J, Linás J, editores. Manual de Demencias. Barcelona: Prous Science, 1996; 407-419.
4. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB: report of the consortium on DLB international workshop). Neurology 1996; 47: 1113-1124.
5. Ditter SM, Mirra AA. Neuropathological and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987; 37: 754-760.
6. Byrne EJ, Lennox G, Loew J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989; 52: 709-717.
7. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of vaying degree- a new disease? Clin Neuropathol 1984; 3: 185-192.
8. Crystal HA, Dickson DW, Lizardi JE, Davies P, Wolfson LI. Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990; 40: 1523-1528.
9. Kosaka K, Iseki E. Dementia with Lewy bodies. Curr Opin Neurol 1996; 9: 271-275.
10. Lennox G, Lowe J, Morrell R, Landom M, Mayer RJ. Antiubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 1989; 52: 67-71.
11. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993; 52: 183-191.
12. Harrington CR, Wischik CM, Hurt J. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau proteins. Dementia 1994; 5: 215-228.
13. Gai WP, Blessing WS, Blumberger PC. Ubiquitin positive degeneration neurites in the brainstem of Parkinson's disease. Brain 1995; 118: 1447-1460.
14. Hansen LA, Galasko D. Lewy Body Disease. Curr Opin Neurol Neurosurg 1992; 5: 889-894.
15. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 1997; 62: 243-252.
16. Hansen LA, Masliah E, Terry RD, Nirra SS. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 1989; 78: 194-201.
17. Gibb WRG, Luthert PJ, Janota I, Lantos PL. Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 1989; 52: 185-192.
18. Louis DE, Goldman JE, Powers JM, Fahn S. Parkinsonian features of eigth pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord 1995; 10: 188-194.
19. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994; 35: 81-88.
20. Connor DJ, Salomon DP, Sandy TJ, Galasko D, Hansen LA, Thal LT. Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. Arch Neurol 1998; 55: 994-1000.
21. Klatka LA, Louis ED, Schiffer RB. Psychiatric features in diffuse Lewy body disease: a clinicopathological study using Alzheimer's disease and Parkinson's disease comparison. Neurology 1996; 47: 1148-1149.
22. Ballard C, MacKeith I. Psychiatry features in diffuse Lewy body disease. Neurology 1998; 50: 573-581.
23. Byrne EJ, Lennox G, Godwin-Austen RP (Notthingham Group for the study of neurodegenerative disorders). Diagnostic criteria for dementia associated with cortical Lewy bodies. Dementia 1991; 2: 283-284.
24. Ala TA, Yang K-H, Sung JH, Frey II WH. Hallucinations and signs of parkinsonim help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation. A clinicopathological study. J Neurol Neurosurg Psychiatry 1997; 62: 16-21.
25. Ballard C, McKeith I, Harrison B, O'Brieb J, Thompson P, Lowery K et al. A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer's disease. Int Psychogeriatr 1997; 9: 381-388.
26. Lois ED, Klatka LA, Liou Y, Fahn S. Comparison of extra-piramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology 1997; 48: 376-380.
27. McKeith IG, Perry RH, Fairbairn AF. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992; 22: 911-922.
28. McKeith IG, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivy in patients with senile dementia of Lewy body type. BMJ 1992; 305: 673-678.
29. Negro PJ, Faber R. Lewy body disease in a patient with REM sleep disorder. Neurology 1996; 46: 1493-1494.
30. Varma AR, Talbot PR, Snowden JS, Lloyd JJ, Testa HJ, Neary D. A 99Tc-HMPAO single-photon emission computed tomography study of Lewy body disease. J Neurol 1997; 244: 349-359.
31. Ishii JK, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaji KH et al. Regional glucose metabolism in dementia with Lewy bodies and Azheimer's disease. Neurology 1998; 51: 125-130.
32. Victoroff J, Mack WJ, Lyness SA, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995; 152: 1476-1484.
33. Snowden MB, Bowen JD, Hughes J, Larson EB. Study of Alzheimer's dementia with parkinsonian features. J Geriat Psychiatry Neurol 1995; 8: 154-158.
34. Gearing M, Schneider JA, Rebeck GW, Hyman BT, Mirra SS. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathological correlates. Neurology 1995; 45: 1985-1990.
35. Martinoli MG, Trojanowski JQ, Schmidt ML, Arnold SE, Fujiwar TM, Lee VM et al. Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol (Berlín) 1995; 90: 239-243.
36. Kalaria RN, Cohen DL, Premkumar DR. Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease. Ann N Y Acad Sci 1996; 777: 266-270.
37. St Clair D, Norrman J, Perry R, Yates C, Wilcosk G, Brookes A. Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett 1994; 1: 45-46.
38. Galasko D, Saitoh T, Xia Y. The apolipoprotein E allele e4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44: 1950-1951.
39. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 1994; 145: 1472-1484.
40. Hardy J, Crook R, Prihar G, Roberts G, Raghavan R, Perry R. Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease. Neurosci Lett 1994; 182: 1-2.
41. Hansen LA, Galasko D, Samuel W, Xia Y, Chen X, Saitoh T. Apolipoproten-E epsilon-4 is associated with increase neurofibrillary pathology in the Lewy body variant of Alzheimer's disease. Neurosci Lett 1994; 182: 63-65.
42. Litvan I, MacInttyre A, Goetz CG, Wenning GK, Jellinger K, Verny M et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies. A clinicopathologic study. Arch Neurol 1998; 55: 969-978.
43. McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferner IN, Thompson P et al. An evaluation of the predictive validity and interrater reliability of clinical diagnositc criteria for senile dementia of Lewy body type. Neurology 1994; 44: 872-877.
44. Kondo N. A study on the difference between clinical and neuropathological diagnoses of age-related dementing illnesses; correlations with Hachinski's ischemic score. Seishin Shinkeigaku Zasshi 1995; 10: 825-846.
45. Langlais PJ, Thai L, Hansen L, Galasko D, Alford M, Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 1993; 43: 1927-1934.
46. Perry EK, Haroutunian V, Davis KL, Lantos P, Eagger S, Honavar M et al. Neocortical Cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 1994; 5: 747-749.
47. Levy R, Egger S, Griffiths M, Perry EK, Honavar M, Dean A et al. Lewy bodies and response to tacrine in Alzheimer's disease. Lancet 1994; 343: 176.